Comparing the expected benefit of plasma cholesterol reduction with or without LDL-C targets in a high-risk, healthy population (2015)
- Authors:
- USP affiliated authors: BITTENCOURT, MÁRCIO SOMMER - HU ; SANTOS FILHO, RAUL DIAS DOS - FM
- Unidades: HU; FM
- Subjects: LIPOPROTEÍNAS LDL; FATORES DE RISCO; RESUMOS (EVENTOS)
- Language: Inglês
- Imprenta:
- Source:
- Título: European Heart Journal
- ISSN: 0195-668X
- Volume/Número/Paginação/Ano: v. 36, supl. 1, p. 2, abst. 70, 2015
- Conference titles: ESC Congress
-
ABNT
CESENA, F. H. et al. Comparing the expected benefit of plasma cholesterol reduction with or without LDL-C targets in a high-risk, healthy population. European Heart Journal. London: Hospital Universitário, Universidade de São Paulo. Disponível em: http://eurheartj.oxfordjournals.org/content/ehj/36/suppl_1/1.full.pdf. Acesso em: 26 dez. 2025. , 2015 -
APA
Cesena, F. H., Laurinavicius, A. G., Bittencourt, M. S., Conceicao, R. D., & Santos, R. D. (2015). Comparing the expected benefit of plasma cholesterol reduction with or without LDL-C targets in a high-risk, healthy population. European Heart Journal. London: Hospital Universitário, Universidade de São Paulo. Recuperado de http://eurheartj.oxfordjournals.org/content/ehj/36/suppl_1/1.full.pdf -
NLM
Cesena FH, Laurinavicius AG, Bittencourt MS, Conceicao RD, Santos RD. Comparing the expected benefit of plasma cholesterol reduction with or without LDL-C targets in a high-risk, healthy population [Internet]. European Heart Journal. 2015 ; 36 2.[citado 2025 dez. 26 ] Available from: http://eurheartj.oxfordjournals.org/content/ehj/36/suppl_1/1.full.pdf -
Vancouver
Cesena FH, Laurinavicius AG, Bittencourt MS, Conceicao RD, Santos RD. Comparing the expected benefit of plasma cholesterol reduction with or without LDL-C targets in a high-risk, healthy population [Internet]. European Heart Journal. 2015 ; 36 2.[citado 2025 dez. 26 ] Available from: http://eurheartj.oxfordjournals.org/content/ehj/36/suppl_1/1.full.pdf - Association between Thyroid-Stimulating Hormone Levels and Non-Alcoholic Fatty Liver Disease Is Not Independent from Metabolic Syndrome Criteria
- The expected cardiovascular benefit of plasma cholesterol lowering with or without LDL-C targets in healthy individuals at higher cardiovascular risk
- Cardiovascular risk and statin eligibility in primary prevention: a comparison between the Brazilian and the AHA/ACC Guidelines
- Achilles tendon xanthomas are associated with the presence and burden of subclinical coronary atherosclerosis in heterozygous familial hypercholesterolemia: A pilot study
- The contribution of the systolic and diastolic components for the diagnosis of arterial hypertension under the 2017 ACC/AHA Guideline and metabolic heterogeneity among individuals with Stage 1 hypertension
- Association between clinical factors and self-underestimation of cardiovascular risk in subjects submitted to a routine health evaluation
- Impact of self-reported fasting duration on lipid profile variability, cardiovascular risk stratification and metabolic syndrome diagnosis
- The obesity paradox on the treadmill: relationship between body mass index and positive exercise stress tests
- Cardiovascular risk stratification and statin eligibility based on the Brazilian vs. North American Guidelines on blood cholesterol management
- Does physical activity influence the association between depressive symptoms and low-grade inflammation in adults?: a study of 8,048 adults
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
